Profit amid loss Many GLP-1 users have seen significant results in losing weight
Second Natures published outcomes data shows members on our GLP-1 programmes lose an average of 19.1% of their starting body weight at 12 months, with 77.7% achieving a clinically meaningful loss of 10% or more
Special Considerations If you cannot tolerate a dose, your healthcare provider may adjust your titration schedule or maintain a lower dose for longer
Slider maxes at 100 mg for easier control
Yuen MF, Heo J, Jang JW, Yoon JH, Kweon YO, Park SJ, Tami Y, You S, Yates P, Tao Y, Cremer J, Campbell F, Elston R, Theodore D, Paff M, Bennett CF, Kwoh TJ
Semaglutide Swiss Elite Laboratories This product contains Semaglutide in a research-grade format intended for laboratory investigation and advanced peptide protocols